Some of the early events following scrapie infection take place in the lymphoreticular system (LRS) and result in significant replication of prions in lymphoid organs. wild-type mice were reconstituted with PrP-deficient lymphohaematopoietic stem cells. Following intraperitoneal inoculation of these mice, no infectivity was found on splenic lymphocytes whereas the stroma (comprising the radiation-resistant, PrP-expressing FDC's) contained prions. These results imply that splenic lymphocytes can acquire prions, possibly from FDC's, but only if they express PrP.
INTRODUCTION
The major clinical and pathological manifestations of prion diseases are found in the central nervous system. Experimentally, the agent is most efficiently transmitted by intracerebral (i.c.) inoculation into the host. However the natural route of infection is more likely via the gastrointestinal tract, which is believed to be the main gateway for the agent in sheep scrapie, kuru, BSE (Anderson et al., 1996; Wilesmith et al., 1992) and likely new variant form of Creutzfeldt-Jakob disease (vCJD) . Peripheral infection, e.g. intraperitoneal (i.p.) infection into laboratory rodents likely mimics the natural infection process more closely than i.c. inoculation.
HOST CELLS IN THE LYMPHORETICULAR SYSTEM INVOLVED IN PRION PROPAGATION
Some of the initial events following scrapie infection take place in the lymphoreticular system (LRS) and result in significant replication of prions in lymphoid organs, prior to neuroinvasion and replication of the agent in the brain (Btieler et al., 1993; Eklund et al., 1967; Fraser and Dickinson, 1970) . It is noteworthy that the host fails to mount a classical immune response to the scrapie agent (Kasper et al., 1982) , presumably because it consists largely or entirely of a host-derived protein. It is not known which cell types in the lymphoreticular system are targets for the scrapie agent and which, if any, mediate its transport to neural sites of replication.
Studies involving splenectomy , whole body irradiation (Fraser and Farquhat, 1987) and spleen fractionation (Clarke and Kimberlin, 1984) suggested that mitotically quiescent cells located in the stromal fraction of the spleen are involved in propagation of the scrapie agent. It was shown by immunohistochemistry that the protease-resistant isoform of PrP colocalizes with follicular dendritic cells (FDCs) in the spleen of prion-infected mice (Kitamoto et al., 1991; Klein et al., 1998; McBride et al., 1992) .
Transport of prions from the periphery to the CNS depends on elements of the LRS, as evidenced by the fact that development of CNS disease after i.p. inoculation with scrapie is impaired or abolished in mice with various forms of immunodeficiency, such as SCID, RAG -/-or tMT mice, while i.c. inoculation continues to be fully effective (Brown et al., 1997; Fraser et al., 1996; Kitamoto et al., 1991; Klein et al., 1997; Lasmezas et al., 1996) . Although these studies strongly suggest an important role for lymphoid cells in the spread of the disease from peripheral sites to the brain, there is also evidence for a direct neural spread of the disease from the periphery to the CNS albeit with a lower efficiency (Beekes et al., 1996; Beekes et al., 1998; Kimberlin and Walker, 1986; Kimberlin and Walker, 1989a; Kimberlin and Walker, 1989b; Lasmezas et al., 1996) . Little is known about the role of lymphocytes in the propagation of the agent.
Fractionation of splenocytes from CJD-infected mice revealed low-density lymphocytes as preferential targets for agent replication. In vitro stimulation of B and T cells with mitogens increased susceptibility to CJD infection (Kuroda et al., 1983) . Similarly, mitogenic activation of the host enhanced susceptibility to scrapie infection and conversely, immunosuppressive treatment of mice reduced susceptibility to scrapie infection . Within the framework of the "protein only" hypothesis this could be explained by the fact that mitogenic activation of lymphocytes results in increased surface expression of PrP (Cashman et al., 1990 ) thereby providing higher levels of substrate for the conversion of PrP C into PrPsc. Taken together, the available data support a participation of cells of various lymphoid origins in agent propagation and disease pathogenesis.
LOCALIZATION OF PRION INFECTIVITY IN THE LRS
To determine which cells in the LRS are carriers of prions, we undertook to analyze the levels of prion infectivity in various subsets of lymphoid cells isolated from scrapie-infected mice.
In a first experiment, we analyzed spleens of wild-type (129/Sv-C57BL/6) mice 34 days after i.p. inoculation with RML prions. At this time point, prion levels reach a maximum in the spleen and stay approximately constant during the whole incubation period (Clarke and Haig, 1971 (Raeber et al., 1999a) . The cell preparations and the stroma fraction were analyzed for infectivity by endpoint titration Fischer et al., 1996) (Figure 1 (Binder et al., 1997) contained only about 1 log LDs0 unit per 106 cells (which could be attributed to the < 2% contamination by T lymphocytes), arguing that prion infectivity in the splenocyte fraction was not due to unspecific contamination with infectivity released from the stromal fraction (Clarke and Kimberlin, 1984 (Raeber et al., 1999a) . Because about 80% of murine PBLs are lymphocytes (Binder et (Raeber et al., 1999b) . Thus, PrP expression in the spleen of the transgenic mice was more than 20-fold higher than in brain, in marked contrast to wild-type mice, where PrP levels in brain exceed those in spleen about 100-fold. PrP on the surface of peripheral blood leukocytes, as determined by cytofluorometry (FACS), was about 10-fold higher in Tg94/IRF than in wild-type mice ( Figure 3C ). High levels of PrP were also observed on B and T lymphocytes of Tg94/IRF splenocytes ( Figure 3A) (Raeber et al., 1999b) . Because a spleen weighs about 100 mg, this represents an increase of 4 logs, showing that prions are replicated in the spleen of intraperitoneally inoculated Tg94/IRF mice and are not due to residual inoculum or import from the brain, which even at 6 months contained no detectable infectivity.
ARE LYMPHOCYTES ABLE TO REPLICATE PRIONS?
We have shown that the LRS efficiently replicates prions after i.p as well as after i.c. infection. To further dissect the host cell types involved in prion replication in the LRS, we targeted PrP expression to lymphocytes and asked whether infectivity is synthesized in the spleen and thymus of such transgenic mice.
PRP KNOCKOUT MICE OVEREXPRESSING PRP IN T CELLS
Transgenic mouse lines with PrP expression restricted to T lymphocytes were generated with the T-lymphocyte-specific Lck promoter (Chaffin et al., 1990) . PrP expression in Tg33/lck mice revealed PrP transcript levels in the thymus at least 50-fold higher than in wild-type (data not shown). Significant levels of PrP mRNA were also found in spleen and kidney. Tg33/lck thymus and spleen had PrP levels that were at least 100-fold and 40-fold higher, respectively, than in wild-type. PrP was undetectable in Tg33/lck brain (Raeber et al., 1999b) . The high level of PrP expression on T lymphocytes was confirmed by FACS analysis of Tg33/lck thymocytes ( Figure 3B ) and estimated to be 50-fold higher than in wild-type. No PrP expression was detected in Tg33/lck splenic B lymphocytes whereas splenic T lymphocytes were strongly positive for PrP ( Figure 3A ). Immunohistochemical analysis of Tg33/lck spleens (Figure 4 , lower panel) showed that PrP expression (red) was predominantly in the perifollicular T cell area while the germinal centers, where the FDCs (green) were located showed little red fluorescence over background (Raeber et al., 1999b (j-m) and Prnp / mice (n-q). Sections were stained with haemalaun (a, e, j, n), antibody FDC-M1 to follicular dendritic cell (green; b, f, k, o), antiserum R340 to PrP (red; c, g, 1, p) and rabbit pre-immune serum (PIS) (d, h, m, q) . In wild-type spleens (k, 1), PrP was stained exclusively in the germinal centers, most strongly in the areas also stained by FDC-M1. In Tg94/IRF mice (b, c), PrP was evenly distributed over the entire section, including the region also stained by FDC-M1. In Tg33/lck spleens, PrP was visualized mainly in the T cell areas but some cells were stained in the region also stained by (Race and Chesebro, 1998; Sailer et al., 1994) . Two weeks and 6 months after i.p. inoculation thymus of wild-type mice had titers of about 3.5 and 4.5 log LDs0 units/ml 10% homogenate, respectively (Raeber et al., 1999b (Montrasio et al., 1999) .
To determine whether PrP C expression in B lymphocytes of Tg306/Igc mice enabled prion replication in the spleen, we assayed spleen extracts from animals sacrificed at 2 and 8 weeks after i.p. inoculation. No infectivity was detected in spleens from scrapie-infected Tg306/Ig: mice (Table I) 
LYMPHOCYTES LACK A HOST COMPONENT REQUIRED FOR PRION REPLICATION
Using ectopic expression of PrP in B or T cells, we showed that expression of PrP C on lymphocytes alone is not sufficient to allow prion replication in thymus or spleen of Prnp / mice. The following explanations can be offered: (1) Lymphocytes are devoid of a conjectural receptor required for prion uptake or lack cellular factor(s) required for prion replication. Several putative PrP receptors have been reported recently (Martins et al., 1997; Rieger et al., 1997; Yehiely et al., 1997), but have not been characterized at the functional level. Experiments with transgenic mice led to the suggestion that a species-specific factor X is required for prion replication (Kaneko et al., 1997; Telling et al., 1995) . (2) Lymphocytes are able to replicate prions but are either rapidly eliminated due to a prion-elicited toxic effect or "washed out" as a result of normal turnover. (3) Finally, it is possible that prions administered i.p. in a PrP knockout environment are not transported or transferred to lymphocytes.
INVOLVEMENT OF STROMAL COMPONENTS IN PRION REPLICATION IN THE LRS
We have shown that prions are replicated in the LRS but that lymphocytes seem to be unable to replicate prions on their own. We have also found that lymphocytes isolated from spleens of scrapie-infected wild-type mice are associated with prions (Raeber et al., 1999a However, prion titers in the stromal fraction were close to those in wild-type mice (Figure 1) (Raeber et al., 1999a) .
In the previous study aimed at localizing prion infectivity in the LRS of wild-type mice, we found prions associated with splenic lymphocytes. We then asked whether association of infectivity with lymphocytes of scrapie-infected wild-type mice was specific or adventitious. Because lymphocytes interdigitate with FDCs (Heinen et al., 1995) , they might have acquired prions or prion-containing, tom-off membrane fragments from the latter during the isolation procedure. However, the finding that wild-type mice reconstituted with PrP-less FLCs show no infectivity on splenic lymphocytes but significant prion titers in the stroma argues that if this "transfer" hypothesis is correct, the postulated adhesion of scrapie agent is dependent on the presence of PrP on lymphocytes; PrP would then function as receptor for the infectious agent. But which cell-type in the LRS replicates prions in the first place?
Prion infectivity in the stromal component of peripheral lymphoid organs is thought to reside in radiation-resistant post-mitotic cells (Fraser and Farquhar, 1987; Fraser et al., 1989) . A prime candidate is the follicular dendritic cell, because the normal isoform of the prion protein, PrP c seems to co-localize with FDCs in uninfected mice (McBride et al., 1992) while PrP sc co-localizes with FDCs in mice inoculated with CJD or scrapie agent (Kitamoto et al., 1991; Klein et al., 1998 (Fu et al., 1998; Mackay and Browning, 1998; Matsumoto et al., 1997) .
Several lines of indirect evidence point to the peripheral nervous system as the crucial compartment that allows prions to get access to the central nervous system (Kimberlin and Walker, 1979; Beekes et al., 1996; Blittler et al., 1997) . It is not clear whether prions can replicate in the peripheral nervous system or whether they are simply transported along nerve fibers. Scrapie prions and PrP sc were found in the peripheral nervous system of a scrapie-sick sheep (Groschup et al., 1996) but so far PrP sc has not been detected in the autonomic peripheral nervous system. Interestingly, the innervation of lymphoid tissue is at least in part controlled by lymphocytes themselves as both T and B cells secrete nerve growth factor and on the other hand nerve terminals secrete a variety of molecules to stimulate the immune system (Straub et al., 1998) .
A thorough understanding of the role of the immune system in peripheral prion pathogenesis is of immediate importance in assessing the risk of iatrogenic transmission of prions and in the development of diagnostic and therapeutic strategies for prion dis- eases.
